NORTHERN TRUST CORP - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 147 filers reported holding FIBROGEN INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$638,700
-71.9%
740,178
-12.1%
0.00%
Q2 2023$2,272,684
-85.4%
841,735
+0.7%
0.00%
-100.0%
Q1 2023$15,603,007
+18.9%
836,174
+2.1%
0.00%0.0%
Q4 2022$13,118,458
+26.3%
818,880
+2.6%
0.00%
+50.0%
Q3 2022$10,388,000
+22.3%
798,408
-0.8%
0.00%0.0%
Q2 2022$8,497,000
-16.5%
804,754
-5.0%
0.00%0.0%
Q1 2022$10,182,000
-20.7%
847,150
-7.0%
0.00%0.0%
Q4 2021$12,845,000
+43.9%
911,017
+4.3%
0.00%0.0%
Q3 2021$8,924,000
-62.9%
873,234
-3.2%
0.00%
-50.0%
Q2 2021$24,033,000
-28.0%
902,490
-6.1%
0.00%
-33.3%
Q1 2021$33,363,000
-13.7%
961,191
-7.8%
0.01%
-25.0%
Q4 2020$38,675,000
-12.8%
1,042,767
-3.4%
0.01%
-20.0%
Q3 2020$44,371,000
+3.0%
1,079,059
+1.5%
0.01%0.0%
Q2 2020$43,076,000
+19.9%
1,062,816
+2.8%
0.01%0.0%
Q1 2020$35,938,000
-18.1%
1,034,206
+1.1%
0.01%0.0%
Q4 2019$43,886,000
+14.9%
1,023,220
-0.9%
0.01%
+11.1%
Q3 2019$38,199,000
-15.0%
1,032,946
+3.8%
0.01%
-18.2%
Q2 2019$44,957,000
-11.8%
995,079
+6.1%
0.01%
-15.4%
Q1 2019$50,972,000
+19.8%
937,831
+2.0%
0.01%
+8.3%
Q4 2018$42,536,000
-23.6%
919,086
+0.2%
0.01%
-14.3%
Q3 2018$55,711,000
-1.5%
917,063
+1.5%
0.01%0.0%
Q2 2018$56,546,000
+47.3%
903,286
+8.7%
0.01%
+40.0%
Q1 2018$38,389,000
-3.3%
830,938
-0.7%
0.01%0.0%
Q4 2017$39,682,000
-10.6%
837,180
+1.5%
0.01%
-16.7%
Q3 2017$44,375,000
+87.0%
824,807
+12.3%
0.01%
+71.4%
Q2 2017$23,724,000
+49.9%
734,483
+14.4%
0.01%
+40.0%
Q1 2017$15,825,000
+21.0%
642,000
+5.0%
0.01%
+25.0%
Q4 2016$13,082,000
+4.9%
611,321
+1.5%
0.00%0.0%
Q3 2016$12,467,000
+27.5%
602,251
+1.1%
0.00%
+33.3%
Q2 2016$9,777,000
-15.0%
595,748
+10.3%
0.00%
-25.0%
Q1 2016$11,496,000
-28.6%
540,012
+2.2%
0.00%
-20.0%
Q4 2015$16,093,000
+43.4%
528,153
+3.2%
0.01%
+25.0%
Q3 2015$11,222,000
+285.4%
511,957
+313.0%
0.00%
+300.0%
Q2 2015$2,912,000
+1.4%
123,948
+35.4%
0.00%0.0%
Q1 2015$2,873,000
+15.4%
91,542
+0.5%
0.00%0.0%
Q4 2014$2,490,00091,0860.00%
Other shareholders
FIBROGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders